Literature DB >> 9865845

Expression of proliferation and apoptosis-related proteins in usual ductal hyperplasia of the breast.

E C Mommers1, P J van Diest, A M Leonhart, C J Meijer, J P Baak.   

Abstract

Expression of proliferation- and apoptosis-related proteins was studied by immunohistochemistry in 130 usual ductal hyperplasias of the breast, of which 39 cases (30%) had adjacent invasive cancer. Overexpression of cyclin D1 and Ki-67 was found in 6% and 29% of the cases, respectively. Only two mild ductal hyperplasias were Her-2/neu positive. Overexpression of p21 and reduced expression of p27, both cdk-inhibitors, was seen in 16% and 27% of the lesions, respectively. Reduced expression of bcl-2 was found in 16% of the cases, and p53 accumulation was present in 8%. Expression of six of the seven studied proteins showed no significant difference between mild, moderate, or florid ductal hyperplasias, indicating that there are no important cell biological differences with regard to the studied proteins between the lesions within this morphologically continuous spectrum. In addition, there were no differences between lesions with and without an invasive component. Cyclin D1 positivity was exclusively seen in lesions with 75% or more p27-positive nuclei. No significant correlations were found between other proteins. Twenty-three of 91 lesions (25%) had multiple events, of which five showed altered expressions of three or four proteins. In conclusion, altered protein expression of several proliferation- and apoptosis-related genes that are known to be involved in invasive breast cancer also may be found in usual ductal hyperplastic lesions, including several lesions with multiple events. This implies that usual ductal hyperplastic lesions may be among the earliest lesions within the breast oncogenetic spectrum.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9865845     DOI: 10.1016/s0046-8177(98)90028-4

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  8 in total

1.  Localised breast cancers may have systemic influences on skin and hair.

Authors:  James S Lawson; Dinh D Tran
Journal:  J Clin Pathol       Date:  2006-06-02       Impact factor: 3.411

Review 2.  Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer.

Authors:  David N Danforth
Journal:  Breast Cancer (Auckl)       Date:  2016-08-17

Review 3.  Chemoprevention of breast cancer: implications for postmenopausal women.

Authors:  Carol J Fabian; Bruce F Kimler
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

4.  Induction of angiogenesis by hyperplastic colonic mucosa adjacent to colon cancer.

Authors:  H Kuniyasu; W Yasui; H Shinohara; S Yano; L M Ellis; M R Wilson; C D Bucana; T Rikita; E Tahara; I J Fidler
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

5.  Multicolor immunofluorescence reveals that p63- and/or K5-positive progenitor cells contribute to normal breast epithelium and usual ductal hyperplasia but not to low-grade intraepithelial neoplasia of the breast.

Authors:  Werner Boecker; Göran Stenman; Tina Schroeder; Udo Schumacher; Thomas Loening; Lisa Stahnke; Catharina Löhnert; Robert Michael Siering; Arthur Kuper; Vera Samoilova; Markus Tiemann; Eberhard Korsching; Igor Buchwalow
Journal:  Virchows Arch       Date:  2017-03-16       Impact factor: 4.064

6.  Lack of lymphangiogenesis during breast carcinogenesis.

Authors:  M M Vleugel; R Bos; P van der Groep; A E Greijer; A Shvarts; H V Stel; E van der Wall; P J van Diest
Journal:  J Clin Pathol       Date:  2004-07       Impact factor: 3.411

7.  Cell cycle related proteins in hyperplasia of usual type in breast specimens of patients with and without breast cancer.

Authors:  Luciene S A Tafuri; Gislene F S Rocha; Helenice Gobbi
Journal:  BMC Cell Biol       Date:  2006-07-26       Impact factor: 4.241

8.  Immunodetectable cyclin D(1)is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions.

Authors:  B S Shoker; C Jarvis; M P Davies; M Iqbal; D R Sibson; J P Sloane
Journal:  Br J Cancer       Date:  2001-04-20       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.